All Ophthalmic

dmscarepharma dmscaren scaled

Sterile ophthalmic solutions and suspensions in multi-dose dropper bottles and preservative-free single-dose units, covering the anti-infective and ocular-surface categories referenced in WHO and MSF eye-care guidance.

Ophthalmic preparations: what the published guidance says

Ophthalmic products face a tighter container specification than any other common dosage form. The WHO Model List names ofloxacin and gentamicin eye drops for conjunctivitis and infectious keratitis, and WHO has issued a specific safety notice for ophthalmic chlorhexidine — a reminder that in eye care the container and the concentration are part of the safety case.

  • The Model List names two anti-infectives for ocular infection Ofloxacin 0.3% eye drops and gentamicin 0.3% eye drops are listed for the treatment of conjunctivitis and infectious keratitis. These two entries define the reference anti-infective range for a public eye-care programme. Source
  • WHO has issued a specific ophthalmic safety notice An information notice from WHO describes serious eye injury following administration of chlorhexidine 7.1% digluconate aqueous solution or gel where the product was placed in the eye in error. The notice is relevant to container design, labelling and pack separation wherever a high-strength antiseptic is supplied alongside eye drops. Source
  • Preservative choice is a clinical and regulatory decision Multi-dose dropper bottles require an antimicrobial preservative with demonstrated preservative efficacy; preservative-free units remove that requirement but change the pack and the price. Both routes are supplied to specification. Source

What to fix in the specification

  • Concentration expressed as % w/v or mg/mL of the active substance
  • Solution or suspension; pH and osmolality limits
  • Container: LDPE dropper bottle with tamper-evident cap, or single-dose unit
  • Dropper nozzle geometry and nominal drop volume
  • Preservative system and preservative efficacy testing
  • Sterility, particulate matter and fill-volume checks

Questions buyers ask

Which eye drops are on the WHO Model List?

Ofloxacin 0.3% and gentamicin 0.3% eye drops are the listed anti-infectives, for conjunctivitis and infectious keratitis. The wider range we supply spans anti-allergic, anti-inflammatory, antiviral and ocular-surface categories.

Can you supply preservative-free eye drops?

Yes. Single-dose preservative-free units and multi-dose bottles with a preservative system are both quoted, with the corresponding preservative efficacy or sterility data in the dossier.

What container do your eye drops use?

LDPE dropper bottles with a tamper-evident cap for multi-dose presentations, or sealed single-dose units where a preservative must be avoided. Nozzle geometry and drop volume are part of the agreed specification.

Ordering and documentation

Every line is quoted against a written specification: monograph, strength, pack configuration, release tests and the documents that ship with the batch. Certificates of analysis, stability data and the GMP certificate accompany each consignment; dossier and registration support are provided where the market requires a filing.

Send a requirement · full product catalogue · therapeutic ranges

Reference information only. Published guidance is quoted for professional and regulatory-context purposes and is not medical advice or a prescribing recommendation.